Investment Opportunities in the US Keytruda Market
The US Keytruda Market represents a compelling investment opportunity in the oncology sector, characterized by robust growth and continuous innovation. Valued at $7.58 billion in 2024, the market is projected to reach $20 billion by 2035, driven by increasing cancer prevalence and expanding therapeutic applications. Investment Drivers The rising incidence of cancer creates sustained...
0 Комментарии 0 Поделились 5 Просмотры 0 предпросмотр